NCT03013270

Brief Summary

This study investigates the effects of aerobic, resistance, inspiratory training modalities outcomes in functional capacity and quality of life of heart failure (HF) patients, aiming for the 'optimum' (greek, αριστος=aristos) training program for HF patients.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
88

participants targeted

Target at P50-P75 for not_applicable heart-failure

Timeline
Completed

Started Sep 2016

Typical duration for not_applicable heart-failure

Geographic Reach
2 countries

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2016

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

December 22, 2016

Completed
15 days until next milestone

First Posted

Study publicly available on registry

January 6, 2017

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2019

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2020

Completed
Last Updated

May 5, 2020

Status Verified

April 1, 2020

Enrollment Period

2.9 years

First QC Date

December 22, 2016

Last Update Submit

May 1, 2020

Conditions

Keywords

RehabilitationExerciseTraining

Outcome Measures

Primary Outcomes (2)

  • change in peak oxygen consumption (peakVO2, in ml/kg/min) using cardiopulmonary exercise testing (Medgraphics CPX/MAX, Medical Graphics Corp.,St. Paul, MN, USA, ZAN 600, ZAN Messgera¨te GmbH, Germany)

    evaluation of maximal exercise capacity

    Before and after 12 weeks

  • change in left ventricular dimension (mm) using resting 2-dimensional echocardiography (Ultrasound Vivid 7 or 6, General Electric Healthcare, Fairfield, CT, USA) with the Teichholz method

    evaluation of cardiac structure (LVEDD, LVESD in mm)

    Before and after 12 weeks

Secondary Outcomes (4)

  • change in walking distance using the 6-minute walking test (6MWT)

    Before and after 12 weeks

  • change in quality of Life using the Minnesota Living with Heart Failure questionnaire

    Before and after 12 weeks

  • Preference Program Survey

    After 12 weeks

  • change in left ventricular ejection fraction, echocardiography (Ultrasound Vivid 7 or 6, General Electric Healthcare, Fairfield, CT, USA) with the biplane Simpson' s method

    Before and after 12 weeks

Other Outcomes (6)

  • Change in dyspnoea using the Borg scale (0-10) at the end of exercise testing

    Before and after 12 weeks

  • Change in maximal inspiratory pressure (PImax in cmH2O) using an electronic pressure manometer with computer software (TRAINAIR®, Project Electronics Ltd, London, UK).

    Before and after 12 weeks

  • Change in inspiratory work capacity (sustained maximal inspiratory pressure (SPImax in cmH2O/s) using an electronic pressure manometer with computer software (TRAINAIR®, Project Electronics Ltd, London, UK).

    Before and after 12 weeks

  • +3 more other outcomes

Study Arms (4)

ARIS group

EXPERIMENTAL

Aerobic-Resistance-Inspiratory

Other: Aerobic-Resistance-Inspiratory

AT/RT group

ACTIVE COMPARATOR

Aerobic-Resistance

Other: Aerobic-Resistance

AT/IMT group

ACTIVE COMPARATOR

Aerobic-Inspiratory

Other: Aerobic-Inspiratory

AT group

ACTIVE COMPARATOR

Aerobic Training

Other: Aerobic Training

Interventions

Patients will be submitted to a 12 week, 3 times/week, continuous aerobic (e.g. bike) training programme at an intensity of 60-80% max HR (or peakVO2) for 30 min combined with resistance training at an intensity of 50% of 1 Repetition Maximum (1RM) for quads training and upper limb exercises (elbow flex/shoulder flex/abd) using dumbbells (1-2 kg) (12-15 reps/3sets) for 10 min, combined also with inspiratory muscle training with a flow-resistive loading system at an intensity of 60% of maximal inspiratory pressure/sustained maximal inspiratory pressure (PImax/SPImax) for 20 min (Aerobic (30min) + Resistance (10min) + Inspiratory (20min) = 60 min)

ARIS group

Patients will be submitted to a 12 week, 3 times/week, continuous aerobic (e.g. bike) training programme at an intensity of 60-80% max HR (or peakVO2) for 30 min combined with resistance training at an intensity of 50% of 1RM for quads training, pectoralis m, serratus anterior m, and latissimus dorsi m and upper limb exercises (elbow flex/shoulder flex/abd) using dumbbells (1-2 kg) (12-15 reps/3sets). (Aerobic (30min) + Resistance (30min) = 60 min)

AT/RT group

Patients will be submitted to a 12 week, 3 times/week, continuous aerobic (e.g. bike) training programme at an intensity of 60-80% max HR (or peakVO2) for 30 min combined with inspiratory muscle training with a flow-resistive loading system at an intensity of 60% of maximal inspiratory pressure/sustained maximal inspiratory pressure (PImax/SPImax) for 30min (Aerobic (30min) + Inspiratory (30min) = 60 min)

AT/IMT group

Patients will be submitted to a 12 week, 3 times/week continuous aerobic (e.g. bike) training programme at an intensity of 60-80% max HR (or peakVO2) for 30 min combined with callisthenics progressing to treadmill or bike (at the same intensity) for 30 min (Aerobic training = 60 min)

AT group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Chronic heart failure (from New York Heart Association (NYHA) functional class II to NYHA III)
  • Left ventricular ejection fraction below or equal to 35%

You may not qualify if:

  • Uncontrolled arrhythmia
  • Pulmonary oedema or pulmonary congestion in the last 30 days
  • Cognitive, neurological or orthopaedic limitations
  • Respiratory infection during 30 days before the start of the study
  • Pulmonary limitations (e.g COPD)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Onassis Cardiac Surgery Center

Athens, Attica, 176 74, Greece

Location

Asklepieion Voulas General Hospital

Voula, Attica, 16673, Greece

Location

Telecardiology Center, Institute of Cardiology

Warsaw, 04-828, Poland

Location

Related Publications (5)

  • Laoutaris ID, Adamopoulos S, Manginas A, Panagiotakos DB, Kallistratos MS, Doulaptsis C, Kouloubinis A, Voudris V, Pavlides G, Cokkinos DV, Dritsas A. Benefits of combined aerobic/resistance/inspiratory training in patients with chronic heart failure. A complete exercise model? A prospective randomised study. Int J Cardiol. 2013 Sep 1;167(5):1967-72. doi: 10.1016/j.ijcard.2012.05.019. Epub 2012 May 31.

    PMID: 22658571BACKGROUND
  • Adamopoulos S, Schmid JP, Dendale P, Poerschke D, Hansen D, Dritsas A, Kouloubinis A, Alders T, Gkouziouta A, Reyckers I, Vartela V, Plessas N, Doulaptsis C, Saner H, Laoutaris ID. Combined aerobic/inspiratory muscle training vs. aerobic training in patients with chronic heart failure: The Vent-HeFT trial: a European prospective multicentre randomized trial. Eur J Heart Fail. 2014 May;16(5):574-82. doi: 10.1002/ejhf.70. Epub 2014 Mar 14.

    PMID: 24634346BACKGROUND
  • Beckers PJ, Denollet J, Possemiers NM, Wuyts FL, Vrints CJ, Conraads VM. Combined endurance-resistance training vs. endurance training in patients with chronic heart failure: a prospective randomized study. Eur Heart J. 2008 Aug;29(15):1858-66. doi: 10.1093/eurheartj/ehn222. Epub 2008 May 30.

    PMID: 18515805BACKGROUND
  • Smart NA. How do cardiorespiratory fitness improvements vary with physical training modality in heart failure patients? A quantitative guide. Exp Clin Cardiol. 2013 Winter;18(1):e21-5.

    PMID: 24294043BACKGROUND
  • Laoutaris ID, Piotrowicz E, Kallistratos MS, Dritsas A, Dimaki N, Miliopoulos D, Andriopoulou M, Manolis AJ, Volterrani M, Piepoli MF, Coats AJS, Adamopoulos S; ARISTOS-HF trial (Aerobic, Resistance, InSpiratory Training OutcomeS in Heart Failure) Investigators. Combined aerobic/resistance/inspiratory muscle training as the 'optimum' exercise programme for patients with chronic heart failure: ARISTOS-HF randomized clinical trial. Eur J Prev Cardiol. 2021 Dec 29;28(15):1626-1635. doi: 10.1093/eurjpc/zwaa091.

MeSH Terms

Conditions

Heart FailureMotor Activity

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesBehavior

Study Officials

  • Stamatis Adamopoulos, MD

    Onassis Cardiac Surgery Center

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD FESC

Study Record Dates

First Submitted

December 22, 2016

First Posted

January 6, 2017

Study Start

September 1, 2016

Primary Completion

August 1, 2019

Study Completion

May 1, 2020

Last Updated

May 5, 2020

Record last verified: 2020-04

Data Sharing

IPD Sharing
Will not share

Locations